Yang Yinshan, Padilla André, Zhang Chi, Labesse Gilles, Kaminski P Alexandre
CNRS, UMR5048, Centre de Biochimie Structurale, Montpellier, France.
J Mol Biol. 2009 Dec 4;394(3):435-47. doi: 10.1016/j.jmb.2009.10.004. Epub 2009 Oct 12.
The gene Rcl encodes a deoxynucleoside 5'-monophosphate N-glycosidase that catalyzes the hydrolysis of the N-glycosidic bond of the nucleotide to give deoxyribose 5-phosphate and a nucleobase, preferentially a purine. This enzyme is over-expressed in several cancers, and its rate of expression is correlated to the degree of aggressiveness of tumors, which makes it a new and attractive therapeutic target. We describe here its structural characterization in the presence of two inhibitory substrate mimics. One of these ligands corresponds to the monophosphorylated form of acyclovir, which is used in the clinic. This study reveals an important ligand-induced stabilization of the dimer structure of the enzyme. The original structural features of Rcl will be helpful for designing new inhibitors.
基因Rcl编码一种脱氧核苷5'-单磷酸N-糖苷酶,该酶催化核苷酸的N-糖苷键水解,生成5-磷酸脱氧核糖和一个核苷碱基,优先为嘌呤。这种酶在几种癌症中过度表达,其表达速率与肿瘤的侵袭程度相关,这使其成为一个新的有吸引力的治疗靶点。我们在此描述了在两种抑制性底物类似物存在下该酶的结构特征。其中一种配体对应于临床上使用的阿昔洛韦的单磷酸化形式。这项研究揭示了配体诱导的该酶二聚体结构的重要稳定性。Rcl的原始结构特征将有助于设计新的抑制剂。